NYSE:CBT • US1270551013
| TTM (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.61B | 3.71B | 3.99B | 3.93B | 4.32B | |||
| Minority Interest Expense | -43.00M | -45.00M | -44.00M | -39.00M | -34.00M | |||
| Cost Of Goods | 2.69B | 2.77B | 3.03B | 3.09B | 3.44B | |||
| Gross Profit | 916.00M | 940.00M | 960.00M | 839.00M | 885.00M | |||
| Operating Expenses | 321.00M | 319.00M | 346.00M | 310.00M | 313.00M | |||
| Research and Development | 58.00M | 59.00M | 63.00M | 57.00M | 55.00M | |||
| Selling, General, and Administrative Expenses | 263.00M | 260.00M | 283.00M | 253.00M | 258.00M | |||
| Operating Income | 595.00M | 621.00M | 614.00M | 529.00M | 572.00M | |||
| Interest Income/Expense | -48.00M | -49.00M | -49.00M | -59.00M | -45.00M | |||
| Other Income/Expense | -8.00M | -7.00M | -36.00M | -16.00M | -9.00M | |||
| Non Recurring Items | N/A | N/A | N/A | -3.00M | -183.00M | |||
| Income Before Taxes | 539.00M | 565.00M | 529.00M | 451.00M | 335.00M | |||
| Income Tax | 192.00M | 196.00M | 111.00M | -28.00M | 102.00M | |||
| Net Income | 306.00M | 326.00M | 374.00M | 437.00M | 206.00M | |||
| EBITDA | 753.00M | 775.00M | 765.00M | 673.00M | 718.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 5.69 | 6.01 | 6.71 | 7.73 | 3.62 | |||
| Non GAAP EPS | 7.03 | 7.26 | 7.06 | 5.38 | 6.26 | |||
| Statistics | ||||||||
| Gross Profit Margin | 25.40% | 25.32% | 24.04% | 21.34% | 20.48% | |||
| Profit Margin | 8.48% | 8.78% | 9.36% | 11.12% | 4.77% | |||
| Operating Profit Margin | 16.50% | 16.73% | 15.37% | 13.46% | 13.24% | |||
All data in USD